Frontlight ResearchEarly access
Trial site
Connecticut Clinical Research Institute
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Eosinophilic oesophagitis2 trials
- Barrett's oesophagus1 trial
- Crohn's disease1 trial
- Phase
- Phase 22 trials
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company1 trial
- Phathom Pharmaceuticals, Inc.1 trial
- Regeneron Pharmaceuticals1 trial
- University of Colorado, Denver1 trial
Running trials
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Barrett's oesophagus1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026